You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 116 No. 4, April 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Analysis of Natural Killer Cell Activity by Flow Cytometry

Tamas Racz, MD; Peter Sacks, PhD; Nguyan T. Van, PhD; Dorothy L. Taylor, MS; Greg Young; Samuel Bugis, MD; Howard E. Savage, PhD; Stimson P. Schantz, MD

Arch Otolaryngol Head Neck Surg. 1990;116(4):440-446.


Abstract

• A flow cytometric assay was used to detect the lytic and binding capacities of both fresh peripheral blood lymphocytes and purified Leu-19+ natural killer cells against head and neck cancer cell lines. Results demonstrated that natural killer cell-mediated cytotoxicity and effector-target conjugate formation evaluated by flow cytometry was significantly correlated with the standard chromium 51 release assay and the single-cell microscopic assay, respectively. The sorted Leu-19+ natural killer cells demonstrated higher lytic capacity with a corresponding higher binding rate compared with the unsorted peripheral blood lymphocytes and sorted Leu-19 cells. Flow cytometric analysis of natural killer cell activity (a rapid, simple, and quantifiable procedure) is an alternative to the standard chromium 51 release assay.

(Arch Otolaryngol Head Neck Surg. 1990;116:440-446)



Author Affiliations

From the Department of Head and Neck Surgery, National Institute of Oncology, Budapest, Hungary (Dr Racz); the Departments of Head and Neck Surgery (Drs Sacks, Savage, and Schantz, Ms Taylor, and Mr Young) and Hematology (Dr Van), The University of Texas MD Anderson Cancer Center, Houston; and the Department of Surgery, Queen's University, Hotel Dieu Hospital, Kingston, Canada (Dr Bugis).


Footnotes

Accepted for publication December 1, 1989.

Reprint requests to the Department of Head and Neck Surgery, Box 69, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 (Dr Schantz).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Natural Killer Cell Activity in Laryngeal Carcinoma
Gonzalez et al.
Arch Otolaryngol Head Neck Surg 1993;119:69-72.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.